EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Lisata Therapeutics's enterprise value is $-17.13 Mil.
Lisata Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil. Therefore, Lisata Therapeutics's EV-to-Revenue for today is .
The historical rank and industry rank for Lisata Therapeutics's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of Lisata Therapeutics was 11.93. The lowest was 0.17. And the median was 2.56.
LSTA's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.94 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for Lisata Therapeutics's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lisata Therapeutics's EV-to-Revenue
For the Biotechnology subindustry, Lisata Therapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lisata Therapeutics's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lisata Therapeutics's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Lisata Therapeutics's EV-to-Revenue falls into.
Lisata Therapeutics's current Enterprise Value is $-17.13 Mil.
Lisata Therapeutics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lisata Therapeutics's share price for today is $3.23.
Lisata Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lisata Therapeutics EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Lisata Therapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Lisata Therapeutics (Lisata Therapeutics) Business Description
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSTA has been successfully added to your 